Prevalence of multiple sclerosis in Sardinia: A systematic cross-sectional multi-source survey

Abstract

Background:

Partial surveys in sub-regions of Sardinia have suggested a high prevalence of multiple sclerosis (MS) on the island, relative to other Mediterranean populations. We assessed the island-wide prevalence of MS and its detailed distribution in Sardinia.

Methods:

The study population consisted of 5677 MS patients, 1735 men and 3942 women, living in Sardinia. Neurologists retrospectively examined electronic and paper-based records of patients with a diagnosis of MS. The data were then linked to the administrative health information systems. Crude, age-, and sex-specific prevalence estimates of disease were calculated.

Results:

The overall age-adjusted MS prevalence was 330 per 100,000 (95% confidence interval (CI) 321–338) in individuals older than 15 years, 447 in women (95% CI 433–461), and 205 in men (95% CI 195–214). The prevalence was highest in the Ogliastra and Nuoro districts, respectively, 425 (95% CI 372–478) and 419 (95% CI 387–451), and lowest in the Olbia-Tempio district, 217 (95% CI 195–239). Most cases had relapsing–remitting MS (79.3%), 16.3% had secondary-progressive MS, and 4.4% had primary-progressive MS.

Conclusion:

These prevalence are among the highest reported so far worldwide. They provide estimates for comparative analyses in other populations and are essential for public health interventions.

Keywords

Epidemiology multiple sclerosis Sardinia prevalence

Get full access to this article

View all access options for this article.

References

Compston

Coles

Multiple sclerosis. Lancet 2008; 372(9648): 1502–1517.

Ernstsson

Gyllensten

Alexanderson

, et al. Cost of illness of multiple sclerosis: A systematic review. PLoS ONE 2016; 11(7): e0159129.

Ebers

GC.

Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7(3): 268–277.

Ascherio

Munger

KL.

Epidemiology of multiple sclerosis: From risk factors to prevention—An update. Semin Neurol 2016; 36(2): 103–114.

Pugliatti

Sotgiu

Rosati

The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002; 104(3): 182–191.

Visser

Wilde

Wilson

, et al. A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry 2012; 83(7): 719–724.

Pugliatti

Riise

Sotgiu

, et al. Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 2005; 25(3): 129–134.

Granieri

Casetta

Govoni

, et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000; 55(6): 842–848.

Cocco

Sardu

Massa

, et al. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 2011; 17(11): 1282–1289.

10.

Polman

Reingold

Banwell

, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292–302.

11.

Kurtzke

JF.

Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33(11): 1444–1452.

12.

Altman

DG.

Practical statistics for medical research. 1st ed. London; New York: Chapman and Hall, 1991.

13.

Warren

Svenson

Warren

KG.

Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler 2008; 14(7): 872–879.

14.

Alonso

Hernan

MA.

Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 2008; 71(2): 129–135.

15.

Bargagli

Colais

Agabiti

, et al. Prevalence of multiple sclerosis in the Lazio region, Italy: Use of an algorithm based on health information systems. J Neurol 2016; 263(4): 751–759.

16.

Rosati

Aiello

Pirastru

, et al. Epidemiology of multiple sclerosis in Northwestern Sardinia: Further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996; 15(1): 10–19.

17.

Casetta

Granieri

Marchi

, et al. An epidemiological study of multiple sclerosis in central Sardinia, Italy. Acta Neurol Scand 1998; 98(6): 391–394.

18.

Pugliatti

Sotgiu

Solinas

, et al. Multiple sclerosis epidemiology in Sardinia: Evidence for a true increasing risk. Acta Neurol Scand 2001; 103(1): 20–26.

19.

Montomoli

Allemani

Solinas

, et al. An ecologic study of geographical variation in multiple sclerosis risk in central Sardinia, Italy. Neuroepidemiology 2002; 21(4): 187–193.

20.

Rosati

Aiello

Mannu

, et al. Incidence of multiple sclerosis in the town of Sassari, Sardinia, 1965 to 1985: Evidence for increasing occurrence of the disease. Neurology 1988; 38(3): 384–388.

21.

Poser

Paty

Scheinberg

, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13(3): 227–231.

22.

Koch-Henriksen

Sorensen

PS.

The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9(5): 520–532.

23.

Simpson

Jr Blizzard

Otahal

, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82(10): 1132–1141.

24.

Benchimol

Manuel

, et al. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol 2011; 64(8): 821–829.

25.

Antoniou

Zagorski

Loutfy

, et al. Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection. PLoS ONE 2011; 6(6): e21748.

26.

Beauchamp

Tonkin

Kelsall

, et al. Validation of de-identified record linkage to ascertain hospital admissions in a cohort study. BMC Med Res Methodol 2011; 11: 42.

27.

Nicoletti

Patti

Lo Fermo

, et al. Increasing frequency of multiple sclerosis in Catania, Sicily: A 30-year survey. Mult Scler 2011; 17(3): 273–280.

28.

Bostrom

Stawiarz

Landtblom

AM.

Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg). Mult Scler 2013; 19(1): 46–52.

29.

Chiang

CWK

Marcus

Sidore

, et al. Genomic history of the Sardinian population. Nat Genet 2018; 50(10): 1426–1434.

30.

International Multiple Sclerosis Genetics Consortium (IMSGC) Beecham

Patsopoulos

, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45(11): 1353–1360.

31.

Belbasis

Bellou

Evangelou

, et al. Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses. Lancet Neurol 2015; 14(3): 263–273.

32.

Francalacci

Morelli

Angius

, et al. Low-pass DNA sequencing of 1200 Sardinians reconstructs European Y-chromosome phylogeny. Science 2013; 341(6145): 565–569.

33.

Sidore

Busonero

Maschio

, et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet 2015; 47(11): 1272–1281.

34.

Steri

Orru

Idda

, et al. Overexpression of the cytokine BAFF and autoimmunity risk. N Engl J Med 2017; 376(17): 1615–1626.

35.

Marrosu

Motzo Murru

Lampis

, et al. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet 2004; 13(23): 2919–2924.

36.

Pugliatti

Rosati

Carton

, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13(7): 700–722.

37.

Cao

Galanello

Beta-thalassemia. Genet Med 2010; 12(2): 61–76.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.17 MB

0.33 MB